Home
|
Inbox
|
Search
|
Speaker
Veit Johannes. Erpenbeck
MD, PhD
Novartis;Novartis Pharma AG
Session(s)
- Fevipiprant, a Potent Selective Antagonist of the Prostaglandin D2 Receptor 2, Modulates t...
Sunday, May 20 11:15 AM - 1:00 PM - Fevipiprant, a Potent Selective Prostaglandin D2 Receptor 2 (DP2) Antagonist, Dose-Depende...
Sunday, May 20 11:15 AM - 1:00 PM - Fevipiprant, a Selective Prostaglandin D2 Receptor 2 Antagonist, Potently Inhibits Chemota...
Tuesday, May 22 2:15 PM - 4:15 PM - Fevipiprant Demonstrates Novel Anti-Inflammatory Effects on Blood and Airway Gene Expressi...
Wednesday, May 23 9:45 AM - 10:00 AM
|
Home
|
Inbox
|
Search
|